• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Absence of p53 mutations in malignant mesotheliomas.

作者信息

Mor O, Yaron P, Huszar M, Yellin A, Jakobovitz O, Brok-Simoni F, Rechavi G, Reichert N

机构信息

Molecular Biology Laboratory, Chaim Sheba Medical Center, Ramat Gan, Israel.

出版信息

Am J Respir Cell Mol Biol. 1997 Jan;16(1):9-13. doi: 10.1165/ajrcmb.16.1.8998073.

DOI:10.1165/ajrcmb.16.1.8998073
PMID:8998073
Abstract

Mutations in the p53 gene are the most common genetic alterations found in human malignancies. In this study, a search was done for mutations in the conserved regions of the p53 gene in malignant mesotheliomas. Thirteen malignant mesotheliomas collected over the preceding 12 yr and maintained in paraffin blocks were examined by polymerase chain reaction (PCR) followed by both single-strand conformation polymorphism (SSCP) and denaturing gradient-gel electrophoresis (DGGE). Direct sequence analysis was performed in cases suspected for mutations. No mutations in exons 5 to 8 of the p53 gene were detected. Our results suggest that malignant transformation of human mesothelioma cells does not require inactivation of p53 by point mutations in the conserved regions of the gene.

摘要

相似文献

1
Absence of p53 mutations in malignant mesotheliomas.
Am J Respir Cell Mol Biol. 1997 Jan;16(1):9-13. doi: 10.1165/ajrcmb.16.1.8998073.
2
Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.原发性人类恶性间皮瘤三种亚型中nf2肿瘤抑制基因的突变分析
Int J Oncol. 2003 May;22(5):1009-17.
3
Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53.
Biotechniques. 1995 May;18(5):742-4.
4
[Mutations of p53 gene in 41 cases of human brain gliomas].41例人脑胶质瘤中p53基因的突变
Ai Zheng. 2008 Jan;27(1):8-11.
5
Mutation spectrum of p53 gene in highly malignant human osteosarcomas.高恶性人骨肉瘤中p53基因的突变谱
Gen Diagn Pathol. 1996 Jun;142(1):25-32.
6
Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism.用于p53突变诊断的标准参考物质的研制:平板凝胶单链构象多态性分析
Electrophoresis. 1998 Feb;19(2):164-71. doi: 10.1002/elps.1150190206.
7
Mutation of the p53 gene in postradiation sarcoma.放疗后肉瘤中p53基因的突变
Lab Invest. 1998 Jun;78(6):727-33.
8
p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.印度咀嚼烟草诱发的口腔癌和白斑中p53基因失活
Oral Oncol. 1999 May;35(3):242-50.
9
Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients.
Ind Health. 2002 Apr;40(2):175-81. doi: 10.2486/indhealth.40.175.
10
Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.通过聚合酶链反应(PCR)和差异杂交检测长期溃疡性结肠炎患者内镜获取的灌洗液中Ki-ras突变,并通过单链构象多态性(SSCP)分析检测p53突变。
Am J Gastroenterol. 1997 Dec;92(12):2166-70.

引用本文的文献

1
Genomics of Tumor Origin and Characteristics for Adenocarcinoma and Malignant Pleural Mesothelioma: A Case Report.腺癌和恶性胸膜间皮瘤的肿瘤起源与特征的基因组学:一例报告
Front Oncol. 2022 May 19;12:858094. doi: 10.3389/fonc.2022.858094. eCollection 2022.
2
Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts.恶性间皮瘤研究的临床前模型:从化学诱导到患者来源的癌症异种移植。
Front Genet. 2018 Jul 4;9:232. doi: 10.3389/fgene.2018.00232. eCollection 2018.
3
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
[Pt(O,O'-乙酰丙酮)(γ-乙酰丙酮)(二甲基亚砜)]诱导的细胞凋亡需要蛋白激酶C-δ介导的p53激活,发生在恶性胸膜间皮瘤中。
PLoS One. 2017 Jul 12;12(7):e0181114. doi: 10.1371/journal.pone.0181114. eCollection 2017.
4
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.恶性胸膜间皮瘤不同组织学亚型中MDM2和HIF1α的表达水平:与病理及临床数据的相关性
Oncotarget. 2015 Dec 8;6(39):42053-66. doi: 10.18632/oncotarget.5974.
5
Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing.利用全基因组测序建立一种新型恶性腹膜间皮瘤细胞系TU-MM-1并进行突变分析。
Hum Cell. 2016 Jan;29(1):46-51. doi: 10.1007/s13577-015-0120-8. Epub 2015 Jun 13.
6
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.利用大规模转录谱分析鉴定恶性胸膜间皮瘤中的新型候选癌基因和肿瘤抑制基因。
Am J Pathol. 2005 Jun;166(6):1827-40. doi: 10.1016/S0002-9440(10)62492-3.
7
Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma.环氧化酶-2(COX-2)及细胞周期抑制剂p21和p27的表达在人胸膜恶性间皮瘤中的预后意义
Thorax. 2004 May;59(5):428-33. doi: 10.1136/thx.2003.008912.
8
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival.p21在SV40大T抗原阳性人胸膜间皮瘤中的表达:与生存的关系
Thorax. 2002 Apr;57(4):353-6. doi: 10.1136/thorax.57.4.353.
9
Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.在间皮瘤中,通过药理学下调bcl-xl可显著增强促凋亡基因治疗效果。
Cancer Gene Ther. 2001 Aug;8(8):547-54. doi: 10.1038/sj.cgt.7700332.
10
p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.恶性间皮瘤患者中的p53自身抗体:疾病进展过程中的稳定性
Br J Cancer. 2001 Jan 5;84(1):52-6. doi: 10.1054/bjoc.2000.1529.